BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 15041461)

  • 21. Identification of two types of ATP-sensitive K+ channels in rat ventricular myocytes.
    Wu SN; Wu AZ; Sung RJ
    Life Sci; 2007 Jan; 80(4):378-87. PubMed ID: 17097686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of terfenadine block of ATP-sensitive K(+) channels.
    Zünkler BJ; Kühne S; Rustenbeck I; Ott T
    Br J Pharmacol; 2000 Aug; 130(7):1571-4. PubMed ID: 10928959
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bradykinin-induced blood-brain tumor barrier permeability increase is mediated by adenosine 5'-triphosphate-sensitive potassium channel.
    Zhang H; Gu YT; Xue YX
    Brain Res; 2007 May; 1144():33-41. PubMed ID: 17331483
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Syntaxin-1A inhibition of P-1075, cromakalim, and diazoxide actions on mouse cardiac ATP-sensitive potassium channel.
    Ng B; Kang Y; Xie H; Sun H; Gaisano HY
    Cardiovasc Res; 2008 Dec; 80(3):365-74. PubMed ID: 18703534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of low-affinity binding sites for glibenclamide on the Kir6.2 subunit of the beta-cell KATP channel.
    Gros L; Virsolvy A; Salazar G; Bataille D; Blache P
    Biochem Biophys Res Commun; 1999 Apr; 257(3):766-70. PubMed ID: 10208857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of sulphonylureas on the volume-sensitive anion channel in rat pancreatic beta-cells.
    Best L; Benington S
    Br J Pharmacol; 1998 Oct; 125(4):874-8. PubMed ID: 9831927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of ATP-sensitive potassium channels in normal and hypertension-associated pregnancy in rats.
    Lima R; Tardim JC; Barros ME; Boim MA
    Clin Exp Pharmacol Physiol; 2006 Sep; 33(9):780-6. PubMed ID: 16922806
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological Profile of U-37883A, a Channel Blocker of Smooth Muscle-Type ATP-Sensitive K Channels.
    Teramoto N
    Cardiovasc Drug Rev; 2006; 24(1):25-32. PubMed ID: 16939631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue selectivity of antidiabetic agent nateglinide: study on cardiovascular and beta-cell K(ATP) channels.
    Hu S; Wang S; Dunning BE
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1372-9. PubMed ID: 10565863
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sustained enhancement of Ca(2+) influx by glibenclamide induces apoptosis in RINm5F cells.
    Iwakura T; Fujimoto S; Kagimoto S; Inada A; Kubota A; Someya Y; Ihara Y; Yamada Y; Seino Y
    Biochem Biophys Res Commun; 2000 May; 271(2):422-8. PubMed ID: 10799313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investigation of the molecular assembly of beta-cell K(ATP) channels.
    Mikhailov MV; Mikhailova EA; Ashcroft SJ
    FEBS Lett; 2000 Sep; 482(1-2):59-64. PubMed ID: 11018523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracellular ATP-sensitive K+ channels in mouse pancreatic beta cells: against a role in organelle cation homeostasis.
    Varadi A; Grant A; McCormack M; Nicolson T; Magistri M; Mitchell KJ; Halestrap AP; Yuan H; Schwappach B; Rutter GA
    Diabetologia; 2006 Jul; 49(7):1567-77. PubMed ID: 16752175
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phospholipids as modulators of K(ATP) channels: distinct mechanisms for control of sensitivity to sulphonylureas, K(+) channel openers, and ATP.
    Krauter T; Ruppersberg JP; Baukrowitz T
    Mol Pharmacol; 2001 May; 59(5):1086-93. PubMed ID: 11306691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions of the sulfonylurea receptor 1 subunit in the molecular assembly of beta-cell K(ATP) channels.
    Mikhailov MV; Ashcroft SJ
    J Biol Chem; 2000 Feb; 275(5):3360-4. PubMed ID: 10652326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The insulin secretory granule is the major site of K(ATP) channels of the endocrine pancreas.
    Geng X; Li L; Watkins S; Robbins PD; Drain P
    Diabetes; 2003 Mar; 52(3):767-76. PubMed ID: 12606519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Study of the insulinotropic effect of the novel antihyperglycemic agent KAD-1229 using HIT T15 cells, a hamster's insulinoma cell line.
    Ichikawa K; Yamato T; Tsuji A; Ojima K; Kusama H; Kojima M
    Arzneimittelforschung; 2002; 52(8):605-9. PubMed ID: 12236048
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Morphological localisation of sulfonylurea receptor 1 in endocrine cells of human, mouse and rat pancreas.
    Guiot Y; Stevens M; Marhfour I; Stiernet P; Mikhailov M; Ashcroft SJH; Rahier J; Henquin JC; Sempoux C
    Diabetologia; 2007 Sep; 50(9):1889-1899. PubMed ID: 17593344
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment and application of in vitro membrane potential assays in cell lines with endogenous or recombinant expression of ATP-sensitive potassium channels (Kir6.2/SUR1) using a fluorescent probe kit.
    Arkhammar P; Wahl P; Gerlach B; Fremming T; Hansen JB
    J Biomol Screen; 2004 Aug; 9(5):382-90. PubMed ID: 15296637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sulfonylureas enhance exocytosis from pancreatic beta-cells by a mechanism that does not involve direct activation of protein kinase C.
    Tian YA; Johnson G; Ashcroft SJ
    Diabetes; 1998 Nov; 47(11):1722-6. PubMed ID: 9792541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells.
    Kramer W; Müller G; Geisen K
    Horm Metab Res; 1996 Sep; 28(9):464-8. PubMed ID: 8911984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.